Table 2.
Distribution of patient characteristics by indicator conditions (primary analysis).
| Indicator condition | Sample size | Agea (reference date: 07/01/2016) |
Genderb |
|
|---|---|---|---|---|
| Mean (standard deviation) | Male (in%) | Female (in%) | ||
| Pneumocystosis | 615 | 56 (15.2) | 64.6 | 35.4 |
| Oral hairy leukoplakia | 158 | 54 (13.6) | 54.4 | 45.6 |
| Kaposi's sarcoma | 998 | 60 (15.2) | 70.0 | 30.0 |
| Syphilis | 12,939 | 57 (17.6) | 59.2 | 40.8 |
| Gonococcal infection | 6305 | 42 (17.3) | 56.0 | 44.0 |
| Acute hepatitis C | 9128 | 52 (12.8) | 59.0 | 41.0 |
| Malignant neoplasm of anus and anal canal | 4791 | 64 (12.4) | 37.7 | 62.3 |
| Chronic viral hepatitis | 9620 | 51 (13.5) | 56.5 | 43.5 |
| Anogenital (venereal) warts | 6261 | 38 (13.1) | 55.7 | 44.3 |
| Chlamydial infection | 6020 | 31 (13.5) | 30.8 | 69.2 |
| Acute hepatitis B | 9975 | 51 (14) | 50.6 | 49.4 |
| Papillomavirus as the cause of diseases | 3887 | 37 (12.5) | 4.3 | 95.7 |
| Tuberculosis | 17,107 | 57 (17.3) | 48.3 | 51.7 |
| Hodgkin's lymphoma | 7981 | 54 (17.1) | 50.2 | 49.8 |
| Acute hepatitis A | 9090 | 57 (15) | 47.3 | 52.7 |
| Pneumonia | 24,013 | 60 (17.5) | 52.2 | 47.8 |
| Non-Hodgkin's lymphoma | 23,271 | 64 (14.4) | 49.2 | 50.8 |
| Infectious mononucleosis | 6858 | 37 (16.3) | 38.7 | 61.3 |
| Herpes simplex infections | 5877 | 50 (18.4) | 30.0 | 70.0 |
| Abnormal weight loss | 4262 | 56 (19.6) | 36.9 | 63.1 |
| Candidiasis | 5146 | 49 (19.1) | 16.5 | 83.5 |
| Herpes zoster | 4635 | 60 (17.4) | 36.4 | 63.6 |
| Dysplasia/malignant neoplasm of cervix uteri | 14,508 | 48 (16.5) | 0.1c | 99.9 |
| Trichomoniasis | 6512 | 42 (15.1) | 14.9 | 85.1 |
| Malignant neoplasm of bronchus and lung | 2467 | 66 (11.2) | 57.6 | 42.4 |
| Seborrheic dermatitis | 6229 | 55 (18.6) | 51.7 | 48.3 |
a
The first date of the data period was chosen as a reference date, so all people in the data were at least 18 years of age (age of majority in Germany).
b
As registered at the insurance institution, the patient has the possibility to change the data.
c
This group might include transgender men with a cervix uteri.